Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ping An Biomedical CoPASW -1.61%17 Equity-to-Asset is 0.66 as of Sep. 2025. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 1,069 Manufacturing - Apparel & Accessories companies, Ping An Biomedical Co ranks better than 67.35% on this metric.
Ping An Biomedical Co (NAS:PASW) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Ping An Biomedical Co Equity-to-Asset Related Terms
Ping An Biomedical Co Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Ping An Biomedical Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PASW vs DXYN, CULP, AIN: Equity-to-Asset Comparison
For the Textile Manufacturing subindustry, Ping An Biomedical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ping An Biomedical Co Equity-to-Asset vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Ping An Biomedical Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Ping An Biomedical Co's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Ping An Biomedical Co's Equity to Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ping An Biomedical Co (PASW) has a Equity-to-Asset of 0.66 as of Sep. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ping An Biomedical Co and its competitors. According to the industry distribution chart, Ping An Biomedical Co ranks #349 out of 1069 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 32.6%.
Is Ping An Biomedical Co's Equity-to-Asset too high?
Ping An Biomedical Co's current Equity-to-Asset is 0.66. The Manufacturing - Apparel & Accessories industry median Equity-to-Asset is 0.55. Ping An Biomedical Co's value of 0.66 is 20% above this industry median. Based on the distribution chart, Ping An Biomedical Co ranks #349 out of 1069 companies in the Manufacturing - Apparel & Accessories industry, which is above the industry midpoint. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's Equity-to-Asset compare to DXYN and CULP?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Ping An Biomedical Co ranks #349 out of 1069 companies for Equity-to-Asset. This puts Ping An Biomedical Co in the upper half of its industry. The industry median Equity-to-Asset is 0.55. Ping An Biomedical Co's value of 0.66 is 20% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Manufacturing - Apparel & Accessories company?
The median Equity-to-Asset among Manufacturing - Apparel & Accessories companies is 0.55, based on 1,069 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ping An Biomedical Co's current Equity-to-Asset of 0.66 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ping An Biomedical Co and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Equity-to-Asset is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ping An Biomedical Co's current Equity-to-Asset is 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current Equity-to-Asset of 0.66. The current Equity-to-Asset is 0.66 and 20% above the Manufacturing - Apparel & Accessories industry median of 0.55. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current Equity-to-Asset is 0.66 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score
Get the complete analysis for PASW
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PASW has been successfully added to your 
